bioRxivImmunologyPreprint
HIV-1 neutralization tiers are not relevant for inhibitors targeting the pre-hairpin intermediate
Abstract
HIV-1 strains are categorized into one of three neutralization tiers based on the relative ease by which they are neutralized by plasma from HIV-1 infected donors not on antiretroviral therapy; tier-1 strains are particularly sensitive to neutralization while tier-2 and tier-3 strains are increasingly difficult to neutralize. Most broadly neutralizing antibodies (bnAbs) previously described target the native prefusion conformation of HIV-1 Envelope (Env), but the relevance of the tiered categories for inhibitors targeting another Env conformation, the pre-hairpin intermediate, is not well understood. Here we show that two inhibitors targeting distinct highly-conserved regions of the pre-hairpin intermediate have strikingly consistent neutralization potencies (within [~]100-fold for a given inhibitor) against strains in all three neutralization tiers of HIV-1; in contrast, best-in-class bnAbs targeting diverse Env epitopes vary by more than 10,000-fold in potency against these strains. Our results indicate that antisera-based HIV-1 neutralization tiers are not relevant for inhibitors targeting the pre-hairpin intermediate and highlight the potential for therapies and vaccine efforts targeting this conformation.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A derivative of the D5 monoclonal antibody that targets the gp41 N-heptad repeat of HIV-1 with broad tier-2 neutralizing activity
A. A. Rubio, M. V. Filsinger Interrante, … P. S. Kim·bioRxiv·Oct 23, 2020
- Assessing bnAb potency in the context of HIV-1 Envelope conformational plasticity
Caio Foulkes, Nikolas Friedrich, … Alexandra Trkola·PLoS PathogensPeer-reviewed·Jan 21, 2025
- Broadly Neutralizing Antibody Epitopes on HIV-1 Particles are exposed after Virus Interaction with Host Cells
P. G. Rao, G. S. Lambert, C. Upadhyay·bioRxiv·Jan 20, 2023
- Distinct region-specific neutralization profiles of contemporary HIV-1 clade C against best-in-class broadly neutralizing antibodies
Jyoti Sutar, Priyanka Jayal, … Jayanta Bhattacharya·Journal of VirologyPeer-reviewed·May 16, 2025
- Neutralizing activity of broadly neutralizing anti-HIV-1 antibodies against primary African isolates
J. C. C. Lorenzi, P. Mendoza, … M. C. Nussenzweig·bioRxiv·Sep 24, 2020
- An HIV-1 broadly neutralizing antibody from a clade C infected pediatric elite neutralizer potently neutralizes the contemporaneous and autologous evolving viruses